Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus
Completed · Phase 2
Conditions studied: Hepatitis C Virus
In brief
The purpose of this study is to assess the safety and efficacy of daclatasvir and simeprevir with and without ribavirin for genotype 1 chronic hepatitis C virus infection in patients who are treatment-naive or null responders to previous pegylated interferon/ribavirin therapy.
Key facts
- Study ID
- NCT01628692
- Run by
- Bristol-Myers Squibb
- People needed
- 230
- Starts
- 2012-07-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2017-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- San Francisco General Hospital — San Francisco, California, United States
- Kaiser Permanente Med Ctr — San Francisco, California, United States
- Indiana University — Indianapolis, Indiana, United States
- Johns Hopkins University — Lutherville, Maryland, United States
- Nashville Medical Research Institute — Nashville, Tennessee, United States
- Texas Clinical Research Institute, Llc — Arlington, Texas, United States
- Metropolitan Research — Fairfax, Virginia, United States
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Créteil, France
- Local Institution — Limoges, France
- Local Institution — Marseille, France
- Local Institution — Paris, France
- Local Institution — Paris, France
- Local Institution — Pessac, France
- Local Institution — Vandœuvre-lès-Nancy, France
- Local Institution — Berlin, Germany
- Local Institution — Cologne, Germany
- Local Institution — Frankfurt, Germany
- Local Institution — Hamburg, Germany
- Local Institution — Budapest, Hungary
- Local Institution — Budapest, Hungary
- Local Institution — Gyula, Hungary
- Local Institution — Barcelona, Spain
- Local Institution — Madrid, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.